300030.SZ
阳普医疗
SZSE · Healthcare · C 制造业 · CN
CNY 6.74
−1.32%Year over year
Reported trailing growth
- Revenue
- -16.1%
- EBITDA
- —
- EBIT
- +136.6%
- EPS
- +126.5%
- Free cash flow
- +207.5%
- Operating cash flow
- +57.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -11.9%
- EBITDA
- +167.1%
- EBIT
- +117.8%
- Net income
- +112.3%
- EPS
- +113.2%
- Free cash flow
- +53.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026